Evidence map›Paper›PMID 22493554›Full record

ArticleWorld journal of gastroenterology2012

Opiate-induced constipation related to activation of small intestine opioid μ2-receptors.

Wency Chen, Hsien-Hui Chung, Juei-Tang Cheng

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effects of Rosa damascena and its compounds on smooth muscle contractility.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2026
    Review
  4. Pharmaceutical biology · 2025
    Article
  5. Postbiotic Potential of Heat-KilledJournal of microbiology and biotechnology · 2025
    Article
  6. Ameliorative Effects of Soybean Powder Fermented byInternational journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Complement C3-Deficiency-Induced Constipation in FVB/N-C3International journal of molecular sciences · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Evaluation of Antidiarrheal Activity of 80% Methanolic Extract of the Leaves ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  17. Article
  18. Frontiers in pharmacology · 2021
    Article
  19. Article
  20. Development of a novel mouse constipation model.World journal of gastroenterology · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wency ChenDepartment of Internal Medicine, E-Da Hospital and I-Shou University, Kaohsiung City, Taiwan 82401, China.
Hsien-Hui Chung
Juei-Tang Cheng
E-Da Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the role of opioid μ-receptor subtype in opiate-induced constipation (OIC).

methodsThe effect of loperamide on intestinal transit was investigated in mice. Ileum strips were isolated from 12-wk-old male BALB/c mice for identification of isometric tension. The ileum strips were precontracted with 1 μmol/L acetylcholine (ACh). Then, decrease in muscle tone (relaxation) was characterized after cumulative administration of 0.1-10 μmol/L loperamide into the organ bath, for a concentration-dependent study. Specific blockers or antagonists were used for pretreatment to compare the changes in loperamide-induced relaxation.

resultsIn addition to the delay in intestinal transit, loperamide produced a marked relaxation in isolated ileum precontracted with ACh, in a dose-dependent manner. This relaxation was abolished by cyprodime, a selective opioid μ-receptor antagonist, but not modified by naloxonazine at a dose sufficient to block opioid μ-1 receptors. Also, treatment with opioid μ-1 receptor agonist failed to modify the muscle tone. Moreover, the relaxation by loperamide was attenuated by glibenclamide at a dose sufficient to block ATP-sensitive K+ (K(ATP)) channels, and by protein kinase A (PKA) inhibitor, but was enhanced by an inhibitor of phosphodiesterase for cyclic adenosine monophosphate (cAMP).

conclusionLoperamide induces intestinal relaxation by activation of opioid μ-2 receptors via the cAMP-PKA pathway to open K(ATP) channels, relates to OIC.

Indexed as

AcetylcholineAnalgesics, OpioidAnimalsAntidiarrhealsConstipationCyclic AMPCyclic AMP-Dependent Protein KinasesGastrointestinal TransitGlyburideHumansIntestine, SmallLoperamideMaleMiceMice, Inbred BALB CMorphinansAcetylcholineAnalgesics, OpioidAntidiarrhealsCyclic AMPCyclic AMP-Dependent Protein KinasescyprodimeGlyburideLoperamideMorphinansnaloxonazineNaloxoneReceptors, Opioid, muATP-sensitive K+ channelsIsometric tensionLoperamideOpioid μ-receptorsSmall intestine

Identifiers

PMID22493554
PMCPMC3319967
OpenAlexW2042340356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.